HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Madeleine Duvic Selected Research

Sezary Syndrome (Sezary Erythroderma)

1/2021Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant hemophagocytic lymphohistiocytosis.
5/2010Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome.
9/2007Vorinostat in cutaneous T-cell lymphoma.
5/2006Treatment of mycosis fungoides with denileukin diftitox and oral bexarotene.
4/2005Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas.
1/2002Treatment of cutaneous T cell lymphoma: current status and future directions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Madeleine Duvic Research Topics

Disease

94Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2022 - 01/2002
73Neoplasms (Cancer)
05/2022 - 03/2002
71Mycosis Fungoides
05/2022 - 01/2002
22Lymphoma (Lymphomas)
05/2021 - 09/2003
17Melanoma (Melanoma, Malignant)
04/2016 - 04/2003
12T-Cell Lymphoma (Lymphoma, T Cell)
01/2020 - 01/2004
12Fatigue
11/2015 - 02/2004
10Hematologic Neoplasms (Hematological Malignancy)
03/2017 - 07/2007
9Disease Progression
05/2021 - 07/2007
9Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 10/2003
8Thrombocytopenia (Thrombopenia)
01/2019 - 02/2004
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2014 - 01/2007
7Primary Cutaneous Anaplastic Large Cell Lymphoma
12/2021 - 10/2009
7Infections
05/2020 - 11/2002
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2020 - 01/2002
7Lymphomatoid Papulosis
02/2019 - 01/2003
6Fever (Fevers)
05/2022 - 02/2004
6Pruritus (Itching)
12/2021 - 03/2002
6Sezary Syndrome (Sezary Erythroderma)
01/2021 - 01/2002
6Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2019 - 12/2005
6Leukemia
01/2019 - 11/2002
6Alopecia Areata
10/2018 - 02/2002
5Skin Neoplasms (Skin Cancer)
09/2014 - 12/2005
5Exanthema (Rash)
03/2014 - 12/2005
5Nausea
06/2012 - 01/2007
5Diarrhea
08/2011 - 01/2007
4Basal Cell Carcinoma (Rodent Ulcer)
05/2019 - 10/2003
4Actinic Keratosis
05/2019 - 12/2010
4Hypertriglyceridemia
09/2017 - 11/2002
4Skin Diseases (Skin Disease)
01/2017 - 02/2008
4B-Cell Lymphoma (Lymphoma, B Cell)
11/2016 - 08/2008
4Keratoacanthoma
07/2014 - 02/2013
4Inflammation (Inflammations)
03/2014 - 08/2004
4Graft vs Host Disease (Graft-Versus-Host Disease)
08/2013 - 01/2002
4Erythema
02/2009 - 08/2003
3Pain (Aches)
12/2021 - 11/2006
3Peripheral Nervous System Diseases (PNS Diseases)
12/2021 - 01/2017
3Pulmonary Embolism
01/2018 - 07/2007
3Sepsis (Septicemia)
01/2018 - 11/2012
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2016 - 04/2009
3Nevus (Nevi)
04/2016 - 08/2009
3Autoimmune Diseases (Autoimmune Disease)
07/2010 - 01/2006
3Anorexia
12/2009 - 11/2006
3Carcinogenesis
11/2008 - 12/2003
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2008 - 11/2002
3T-Cell Leukemia (Leukemia, T Cell)
03/2008 - 07/2004
2Pseudolymphoma
01/2022 - 04/2003
2Dermatitis
11/2019 - 08/2004
2Rheumatoid Arthritis
01/2019 - 01/2006
2Edema (Dropsy)
01/2019 - 12/2005
2Follicular Mucinosis
05/2018 - 01/2003

Drug/Important Bio-Agent (IBA)

20Bexarotene (LGD1069)FDA Link
12/2021 - 03/2002
15denileukin diftitox (Ontak)FDA Link
11/2017 - 01/2002
12Pharmaceutical PreparationsIBA
05/2022 - 01/2004
12Histone Deacetylase InhibitorsIBA
02/2016 - 11/2005
11VorinostatFDA Link
01/2021 - 11/2005
10RetinoidsIBA
02/2009 - 11/2002
9Brentuximab VedotinIBA
12/2021 - 11/2015
8Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2002
7mogamulizumabIBA
01/2022 - 03/2015
7SteroidsIBA
01/2019 - 03/2003
7Biomarkers (Surrogate Marker)IBA
01/2018 - 10/2003
6Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 05/2010
6Anti-Bacterial Agents (Antibiotics)IBA
05/2020 - 08/2004
6romidepsin (FK228)FDA Link
01/2018 - 10/2010
6AntigensIBA
04/2017 - 12/2002
6Histone Deacetylases (Histone Deacetylase)IBA
03/2017 - 11/2005
5Monoclonal AntibodiesIBA
01/2021 - 08/2004
5Biological ProductsIBA
04/2020 - 01/2006
5Mechlorethamine (Nitrogen Mustard)FDA Link
01/2015 - 03/2003
5InterferonsIBA
10/2014 - 01/2003
5VemurafenibIBA
07/2014 - 01/2013
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2018 - 12/2014
410-propargyl-10-deazaaminopterinFDA Link
07/2017 - 03/2008
4LigandsIBA
02/2017 - 07/2010
4Isotretinoin (Accutane)FDA LinkGeneric
09/2006 - 01/2003
3IntegrinsIBA
09/2019 - 03/2011
3Lenalidomide (CC 5013)FDA Link
01/2019 - 04/2008
3MutagensIBA
04/2016 - 12/2005
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2016 - 03/2009
3Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
02/2009 - 01/2003
3tazarotene (Tazorac)FDA Link
02/2009 - 10/2003
3Messenger RNA (mRNA)IBA
11/2008 - 10/2003
3GemcitabineFDA Link
02/2007 - 07/2006
3CytokinesIBA
12/2006 - 08/2004
3Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2006 - 01/2003
2pembrolizumabIBA
01/2020 - 01/2019
2Immune Checkpoint InhibitorsIBA
01/2020 - 11/2019
2Interleukin-1 (Interleukin 1)IBA
09/2019 - 05/2019
2Imiquimod (Aldara)FDA LinkGeneric
05/2019 - 09/2017
2Alanine Transaminase (SGPT)IBA
01/2019 - 11/2006
2MicroRNAs (MicroRNA)IBA
11/2018 - 01/2016
2MucinsIBA
05/2018 - 01/2003

Therapy/Procedure

87Therapeutics
05/2021 - 01/2002
16Drug Therapy (Chemotherapy)
05/2021 - 02/2003
12Photopheresis
03/2022 - 01/2002
12Radiotherapy
05/2021 - 01/2003
5Aftercare (After-Treatment)
10/2020 - 01/2006
3Stem Cell Transplantation
10/2016 - 01/2006
2Intravenous Infusions
01/2019 - 06/2015